SMS Pharmaceuticals Limited — Others, 24-03-2025: Action(s) initiated or orders passed

SMS Pharmaceuticals has received a demand notice from the Income Tax Department for ₹45.63 Crores, citing adjustments to the income for the Assessment Year 2023-24. The company is appealing this order within the established timelines, which indicates a proactive approach to manage potential liabilities. While this situation may raise concerns about financial exposure, the company asserts that it will not impact its current operations. Investors may see this as a neutral impact, though understanding the outcome of the appeal will be key to assessing any future risks or adjustments to financial forecasts.